Coronary atherosclerosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients 20 years of age or older at the time of percutaneous coronary intervention(PCI) (2) Patients who underwent PCI with directional coronary atherectomy and had a plaque collected (3) Patients for whom written consent has been obtained by the individual
Exclusion criteria
Exclusion criteria: (1) Patients taking steroids, autoimmune diseases, undergoing treatment for cancer, or suffering from hepatitis B and C viruses (2) Other patients who are deemed inappropriate by the physician in charge of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cluster analysis of single-cell RNA sequencing and cluster analysis of gene expression variation in each cluster on both stable and unstable coronary atherosclerosis | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between plaque assessment collected by DCA and various plaque data 1.Plaque evaluation by CT 2.Plaque assessment by cMRI 3. Bulk RNA sequencing 4. microRNA sequencing 5. Histological evaluation | — |
Countries
Japan
Contacts
Hyogo Brain and Heart Centor The division of Cardiovascular medicine